Effect of myocardial ischemia on cardiac troponin I and T - 02/09/11
Doi : 10.1016/S0002-9149(01)02206-8
Raymond J Carlson, MD a, Anthony Navone, MD a, Joseph P McConnell, PhD c, Mary Burritt, PhD c, Martha C Castle, RN a, Diane Grill, MS d, Allan S Jaffe, MD ⁎, b, c, 
a Crouse Hospital, Syracuse, New York, USA
b Division of Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota, USA
c Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA
d Department of Biostatistics, Mayo Clinic, Rochester, Minnesota, USA
*Dr. Jaffe’s address is: Mayo Building, 16th Floor, 200 First St. SW, Rochester, Minnesota, USA
 | This study was supported in part by Dade Behring, Newark, Delaware. |
© 2002
Excerpta Medica Inc. Tous droits réservés.
Vol 89 - N° 2
P. 224-226 - janvier 2002 Retour au numéro
Article précédent
- Comparison of one-year outcomes after percutaneous coronary intervention among current smokers, ex-smokers, and nonsmokers
- Dale T Ashby, George Dangas, Roxana Mehran, Alexandra J Lansky, Martin P Fahy, Ioannis Iakovou, Lowell F Satler, Augusto D Pichard, Kenneth M Kent, Gregg W Stone, Martin B Leon
- Dose response, safety, and efficacy of an extended-release formulation of lovastatin in adults with hypercholesterolemia
- John R Crouse, Peter Lukacsko, Robert Niecestro, The Lovastatin Extended-Release Study Group
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?